The American company Pfizer first refused the RNA vaccine developed by the German pharmaceutical company Biontech, as it was considered that coronavirus infection would be quickly defeated. This was told in an interview with the newspaper The Daily Telegraph General Director and Co-founder Biontech Ugur Shahin.
“Guys, it will not work. My working hypothesis is that it (COVID-19) will be controlled soon,” replied the vice-president and chief scientific specialist in vaccines in Pfizer Phil Dormitzer during a phone call At the beginning of 2020, I remembers Shahin, reports TASS.
“After a telephone conversation with Phil, I thought a second and said:” We will call him again in a few weeks, “said the head of BionTech.
Shahin and his spouse, Director of Medical Research by Biontech, We were confident that the consent of the American pharmaceutical giant is only a matter of time, and were right. As stated in the article, after a month they concluded a deal. The development of a joint vaccine was announced in March 2020. Until now, about 1.4 billion doses of the Biontech of the drug were supplied in 120 countries, and the cost of the company is estimated at $ 85 billion
In March of this year, Shahin and Tüchchi, who immigrated to Germany from Turkey in childhood, were awarded the Order “For Merit to the Federal Republic of Germany” – the only Federal Order of the FRG. They are awarded residents of Germany and foreign citizens for special merits in front of Germany in the field of politics and economics, as well as in social, spiritual and charitable spheres.